#1 Clinical Trials Search in Europe

Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

↓

Matched clinical trials

  • A Study of Pacritinib for Reducing Bone Marrow Scarring in Patients with Myelofibrosis Who Have Low Platelet Counts

    Recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Spain

  • Study of RVU120 treatment in patients with myelodysplastic syndrome, solid tumors, or acute myeloid leukemia who benefited from previous RVU120 therapy

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    France Italy Poland Spain

  • Study on the Safety of Roginolisib and Ruxolitinib for Patients with Myelofibrosis Unresponsive to JAK Inhibitors

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy Spain

  • Study of TP-3654 and Momelotinib for Patients with Intermediate or High-risk Myelofibrosis

    Recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium Bulgaria Czechia Denmark France +7

  • Study of RVU120 and Ruxolitinib for Patients with Intermediate or High-Risk Myelofibrosis

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy Poland

  • Study on Long-Term Safety of Pelabresib for Patients with Myelofibrosis or Essential Thrombocythemia

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Italy The Netherlands

  • Study on Adding Navtemadlin to Ruxolitinib for Patients with Myelofibrosis and Suboptimal Response to Ruxolitinib

    Recruiting

    1 1 1
    Investigated drugs:
    Austria Belgium Croatia Czechia France Germany +7

  • Study on Long-Term Safety of Luspatercept for Patients with Myelodysplastic Syndrome, Beta-Thalassemia, or Myelofibrosis Who Previously Participated in Luspatercept Trials

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Bulgaria France Germany Greece Italy The Netherlands +2

  • Study on the Safety of Bomedemstat for Patients with Myeloproliferative Neoplasms Who Participated in a Previous Bomedemstat Study

    Recruiting

    1 1 1
    Investigated diseases:
    Italy

  • Study for Myelofibrosis Patients Using Ruxolitinib or Ruxolitinib with Other Cancer Treatments

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Poland